Association of early-onset Alzheimer's disease with an interleukin-1α gene polymorphism

Annals of Neurology

Volumn 47, Issue 3, 2000, Pages 361-365

  Grimaldi, Luigi M E ^a,b,g   Casadei, Valeria M ^a   Ferri, Cinzia ^a   Veglia, Fabrizio ^b   Licastro, Federico ^e   Annoni, Giorgio ^a   Biunno, Ida ^c   De Bellis, Gianluca ^c   Sorbi, Sandro ^f   Mariani, Claudio ^d   Canal, Nicola ^a   Griffin, W Sue T ^h   Franceschi, Massimo ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c CNR   (Italy)

^d IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f UNIVERSITY OF FLORENCE   (Italy)

^g OASI RESEARCH INSTITUTE IRCCS   (Italy)

^h UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1ALPHA;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CORRELATION FUNCTION; FEMALE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENILE PLAQUE;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; FEMALE; GENOTYPE; HUMANS; INTERLEUKIN-1; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 17644438751     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200003)47:3<361::AID-ANA12>3.0.CO;2-N     Document Type: Article

References (21)

1. Griffin WST, Sheng JG, Royston MC, et al. Glial-neuronal interactions in Alzheimer's disease: the potential role of a cytokine cycle in disease progression. Brain Pathol 1998;8:65-72
2. Griffin WST, Stanley LC, Ling C, et al. Brain interleukin 1 and S-100 immunoreactiviry are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 1989;86:7611-7615
3. Sheng JG, Mrak RE, Griffin WST. Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease. Neuropathol Appl Neurol 1998;24:278-283
4. Sheng JG, Mrak RE, Griffin WST. Glial-neuronal interactions in Alzheimer's disease: progressive association of IL-1α microglia and S100β astrocytes with neurofibrillary tangle stages. J Neuropathol Exp Neurol 1997;56:285-290
5. Sheng JG, Zhou XQ, Mrak RE, Griffin WST. Progressive neuronal injury associated with neurofibrillary tangle formation in Alzheimer's disease. J Neuropathol Exp Neurol 1998;57:323-328
6. Sheng JG, Mrak RE, Griffin WST. Interleukin-1α expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution. Neuropathol Appl Neurol 1995;21:290-301
7. Goldgaber D, Harris HW, Hla T, et al. Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci USA 1989;86:7606-7610
8. Buxbaum JD, Oishi M, Chen HI, et al. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proc Natl Acad Sci USA 1992;89:10075-10078
9. Dinarello CA. Biological basis for interleukin 1 in disease. Blood 1996;87:2095-2147
10. Tarra L, McDowell TL, Symons JA, et al. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism. Arthritis Rheum 1995;38:221-228
11. Huang DR, Pirskanene R, Hjelmstrom P, Lefvert AK. Polymorphisms in IL-1 β and IL-1 receptor antagonist genes are associated with myasthenia gravis. J Neuroimmunol 1998;81: 76-81
12. Kornman KS, Crane A, Wang H-Y, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997;24:72-77
13. Sciacca FL, Vandenbroeck K, Ferri C, et al. Relevance of the interleukin 1 receptor antagonist intron 2 polymorphism in Italian multiple sclerosis patients. Neurology 1999;52:1896-1898
14. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944
15. Maggi S, Zucchetto M, Grigoletto F, Amaducci L. The Italian Longitudinal Study on Ageing (ILSA): design and methods. Aging 1994;6:464-473
16. Grigoletto F, Zappalà G, Dallas WA, et al. Norms for the Mini-Mental State Examination in a healthy population. Neurology 1999;53:315-320
17. Di Giovine FS, Takhash E, Blakemore AIF, Duff GW. Single base polymorphism at -511 in the human interleukin-1β gene (IL1β). Hum Mol Genet 1992;6:450
18. Tarlow JK, Blakemore AIF, Lennard A, et al. Polymorphism in the human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993;91:403-404
19. Crook R, Hardy J, Duff K. Single-day apolipoprotein E genotyping. J Neurosci Methods 1994;53:125-127
20. Mayeux R, Ottman R, Tang MX, et al. Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives. Ann Neurol 1993;33:494-501
21. Papassotiropoulos A, Bagli M, Jessen F, et al. A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease. Ann Neurol 1999;45:666-668